Browsing Tag
CVS Caremark
4 posts
Samsung Epis beats growth expectations in Q1 as Bioepis expands global partnerships
Samsung Epis Holdings reported strong Q1 2026 growth. Read how Samsung Bioepis, new partnerships, and pipeline bets could shape what comes next.
CVS stock slips as Aetna settles Medicare Advantage diagnosis code fraud case for $117.7m
CVS Health's Aetna to pay $117.7M over Medicare Advantage diagnosis code fraud. Read what this means for CVS stock and managed care enforcement.
Why CVS Caremark’s decision to drop Zepbound could reshape the billion-dollar weight-loss drug war
CVS Caremark faces a lawsuit after dropping Eli Lilly’s Zepbound from coverage. Explore patient, investor, and payer implications in the GLP-1 market battle.
Zydus Lifesciences posts strong Q3 FY25 results with 30% net profit surge
Zydus Lifesciences Limited has reported robust financial performance for the third quarter of fiscal year 2025, driven by…